speb/financial-data huggingface dataset:
IVZ cash_flow (annual, 2024-12-31) — Operating Gains Losses: 14900000.00
IVZ income_statement (annual, 2024-12-31) — Operating Income: 832100000.00
IVZ income_statement (annual, 2024-12-31) — Operating Revenue: 5868400000.00
IVZ balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 448000000.00
IVZ balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -1036100000.00
IVZ income_statement (annual, 2024-12-31) — Other Gand A: 594700000.00
IVZ income_statement (annual, 2024-12-31) — Other Income Expense: 172300000.00
IVZ balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 5749300000.00
IVZ balance_sheet (annual, 2024-12-31) — Other Investments: 14300000.00
IVZ cash_flow (annual, 2024-12-31) — Other Non Cash Items: -89800000.00
IVZ balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1120700000.00
IVZ balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 652200000.00
IVZ income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 129300000.00
IVZ income_statement (annual, 2024-12-31) — Other Operating Expenses: 474300000.00
IVZ balance_sheet (annual, 2024-12-31) — Other Payable: 69400000.00
IVZ balance_sheet (quarterly, 2024-12-31) — Other Payable: 69400000.00
IVZ income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
IVZ balance_sheet (annual, 2024-12-31) — Payables: 246000000.00
IVZ balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 830400000.00
IVZ balance_sheet (annual, 2024-12-31) — Preferred Stock: 4010500000.00
IVZ cash_flow (annual, 2024-12-31) — Preferred Stock Dividend Paid: -236800000.00
IVZ income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 236800000.00
IVZ balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 4010500000.00
IVZ cash_flow (annual, 2024-12-31) — Preferred Stock Payments: 0.00
IVZ income_statement (annual, 2024-12-31) — Pretax Income: 1005300000.00
IVZ balance_sheet (annual, 2024-12-31) — Properties: 0.00
IVZ balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
IVZ cash_flow (annual, 2024-12-31) — Purchase Of Investment: -4469000000.00
IVZ cash_flow (annual, 2024-12-31) — Purchase Of PPE: -69100000.00
IVZ balance_sheet (annual, 2024-12-31) — Receivables: 6906100000.00
IVZ income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 3905000000.00
IVZ income_statement (annual, 2024-12-31) — Reconciled Depreciation: 179600000.00
IVZ cash_flow (annual, 2024-12-31) — Repayment Of Debt: -4681200000.00
IVZ cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -79300000.00
IVZ income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
IVZ income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
IVZ balance_sheet (annual, 2024-12-31) — Retained Earnings: 6990400000.00
IVZ cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
IVZ cash_flow (annual, 2024-12-31) — Sale Of Investment: 4479700000.00
IVZ income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 81300000.00
IVZ income_statement (annual, 2024-12-31) — Selling General And Administration: 676000000.00
IVZ balance_sheet (annual, 2024-12-31) — Share Issued: 566100000.00
IVZ income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
IVZ income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
IVZ cash_flow (annual, 2024-12-31) — Stock Based Compensation: 104600000.00
IVZ balance_sheet (annual, 2024-12-31) — Stockholders Equity: 14559900000.00
IVZ balance_sheet (annual, 2024-12-31) — Tangible Book Value: -3518000000.00
IVZ income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
IVZ income_statement (annual, 2024-12-31) — Tax Provision: 252900000.00
IVZ income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.25
IVZ balance_sheet (annual, 2024-12-31) — Total Assets: 27008900000.00
IVZ balance_sheet (annual, 2024-12-31) — Total Capitalization: 21651400000.00
IVZ balance_sheet (annual, 2024-12-31) — Total Debt: 7546400000.00
IVZ balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 15668800000.00
IVZ income_statement (annual, 2024-12-31) — Total Expenses: 5234900000.00
IVZ balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 11340100000.00
IVZ balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 18606800000.00
IVZ balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 10509700000.00
IVZ income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 832100000.00
IVZ balance_sheet (annual, 2024-12-31) — Total Tax Payable: 146000000.00
IVZ balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 146000000.00
IVZ income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
IVZ income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
IVZ income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
IVZ income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
IVZ balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 118100000.00
IVZ balance_sheet (annual, 2024-12-31) — Treasury Stock: 2852700000.00
IVZ balance_sheet (annual, 2024-12-31) — Working Capital: 7571700000.00
IVZ income_statement (quarterly, 2025-03-31) — +Operating Expense: 278300000.00
IVZ income_statement (quarterly, 2025-03-31) — +Total Revenue: 1529200000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1415700000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1131100000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 7235800000.00
IVZ income_statement (quarterly, 2025-03-31) — Amortization: 10100000.00
IVZ income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 10100000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 6973500000.00
IVZ income_statement (quarterly, 2025-03-31) — Basic Average Shares: 452900000.00
IVZ income_statement (quarterly, 2025-03-31) — Basic EPS: 0.38
IVZ cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 1496000000.00
IVZ cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -23400000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Capital Stock: 4123700000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1873400000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1873400000.00
IVZ cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -151700000.00
IVZ cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 529300000.00
IVZ cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -92000000.00
IVZ cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -84600000.00
IVZ cash_flow (quarterly, 2025-03-31) — Change In Payable: -311800000.00
IVZ cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -311800000.00
IVZ cash_flow (quarterly, 2025-03-31) — Change In Receivables: -205900000.00
IVZ cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -517700000.00
IVZ cash_flow (quarterly, 2025-03-31) — Changes In Cash: 352700000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Common Stock: 113200000.00
IVZ cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -92500000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 10688200000.00
IVZ cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -43100000.00
IVZ income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 973600000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Current Assets: 9477700000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1415700000.00
IVZ cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 41500000.00
IVZ income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 10100000.00
IVZ cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 41500000.00
IVZ income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 10100000.00
IVZ income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 454000000.00
IVZ income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.38
IVZ income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 171100000.00
IVZ cash_flow (quarterly, 2025-03-31) — Dividend Received Cfo: 5900000.00
IVZ cash_flow (quarterly, 2025-03-31) — Dividends Received Cfi: 42600000.00
IVZ income_statement (quarterly, 2025-03-31) — EBIT: 358000000.00
IVZ income_statement (quarterly, 2025-03-31) — EBITDA: 399500000.00
IVZ income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 19600000.00
IVZ cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: -19600000.00
IVZ cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 24700000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 542900000.00
IVZ cash_flow (quarterly, 2025-03-31) — End Cash Position: 1873400000.00
IVZ cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 529300000.00
IVZ cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -108000000.00
IVZ cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -44400000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -947900000.00
IVZ income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 137300000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Goodwill: 8373000000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 14119600000.00
IVZ income_statement (quarterly, 2025-03-31) — Gross Profit: 555600000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 683300000.00
IVZ income_statement (quarterly, 2025-03-31) — Interest Expense: 13100000.00
IVZ income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 13100000.00
IVZ income_statement (quarterly, 2025-03-31) — Interest Income: 11300000.00
IVZ income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 11300000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Invested Capital: 11653000000.00
IVZ cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -92000000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Investment Properties: 421100000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 1183600000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 2414800000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Investments In Other Ventures Under Equity Method: 1216400000.00
IVZ cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 1891600000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Loans Receivable: 6473200000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 964800000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 964800000.00
IVZ cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 1891600000.00
IVZ cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -1134900000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 1216400000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Minority Interest: 1088700000.00
IVZ income_statement (quarterly, 2025-03-31) — Minority Interests: -37000000.00
IVZ cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -43100000.00
IVZ income_statement (quarterly, 2025-03-31) — Net Income: 230300000.00
IVZ income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 171100000.00
IVZ income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 267300000.00
IVZ income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 230300000.00
IVZ income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 230300000.00
IVZ cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 267300000.00
IVZ income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 267300000.00
IVZ income_statement (quarterly, 2025-03-31) — Net Interest Income: -1800000.00
IVZ cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -111200000.00
IVZ cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 756700000.00
IVZ cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 756700000.00
IVZ income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -1800000.00
IVZ cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -32600000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Net PPE: 458400000.00
IVZ cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -23400000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 579100000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 1328400000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 1328400000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Non Current Note Receivables: 6473200000.00
IVZ income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 399500000.00
IVZ income_statement (quarterly, 2025-03-31) — Normalized Income: 230300000.00
IVZ cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -84600000.00
IVZ cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -64000000.00
IVZ income_statement (quarterly, 2025-03-31) — Operating Income: 277300000.00
IVZ income_statement (quarterly, 2025-03-31) — Operating Revenue: 1474700000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 447556286.00
IVZ balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -947900000.00
IVZ income_statement (quarterly, 2025-03-31) — Other Gand A: 137300000.00
IVZ income_statement (quarterly, 2025-03-31) — Other Income Expense: 69400000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 5746600000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Other Investments: 14800000.00
IVZ cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 167200000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1252000000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 8104400000.00
IVZ income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 49800000.00
IVZ income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 113900000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Payables: 1415700000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1415700000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 4010500000.00
IVZ cash_flow (quarterly, 2025-03-31) — Preferred Stock Dividend Paid: -59200000.00
IVZ income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 59200000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 4010500000.00
IVZ income_statement (quarterly, 2025-03-31) — Pretax Income: 344900000.00
IVZ cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -829100000.00
IVZ cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -23400000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Receivables: 7604300000.00
IVZ income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 942200000.00
IVZ income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 41500000.00
IVZ cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -1134900000.00
IVZ cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -43100000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 7069000000.00
IVZ cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 717900000.00
IVZ income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 17000000.00
IVZ income_statement (quarterly, 2025-03-31) — Selling General And Administration: 154300000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Share Issued: 566056286.00
IVZ cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 15200000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 14698700000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -3431400000.00
IVZ income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
IVZ income_statement (quarterly, 2025-03-31) — Tax Provision: 77600000.00
IVZ income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.22
IVZ balance_sheet (quarterly, 2025-03-31) — Total Assets: 28143600000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 15663500000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Total Debt: 964800000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 15787400000.00
IVZ income_statement (quarterly, 2025-03-31) — Total Expenses: 1251900000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 12356200000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 18665900000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 10940500000.00
IVZ income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 277300000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 118500000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 2781900000.00
IVZ balance_sheet (quarterly, 2025-03-31) — Working Capital: 8062000000.00
IVZ income_statement (quarterly, 2025-06-30) — +Operating Expense: 290200000.00
IVZ income_statement (quarterly, 2025-06-30) — +Total Revenue: 1515500000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1431800000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 1102800000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 7250100000.00
IVZ income_statement (quarterly, 2025-06-30) — Amortization: 9700000.00
IVZ income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 9700000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 512900000.00
IVZ income_statement (quarterly, 2025-06-30) — Basic Average Shares: 453800000.00
IVZ income_statement (quarterly, 2025-06-30) — Basic EPS: -0.03
IVZ cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1873400000.00
IVZ cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -17500000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Capital Stock: 3123700000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1491900000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1491900000.00
IVZ cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -151800000.00
IVZ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -724800000.00
IVZ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -275400000.00
IVZ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 547900000.00
IVZ cash_flow (quarterly, 2025-06-30) — Change In Payable: 179100000.00
IVZ cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 179100000.00
IVZ cash_flow (quarterly, 2025-06-30) — Change In Receivables: 179800000.00
IVZ cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 358900000.00
IVZ cash_flow (quarterly, 2025-06-30) — Changes In Cash: -452300000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Common Stock: 113200000.00
IVZ cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -95200000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 10862600000.00
IVZ cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -25500000.00
IVZ income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1011100000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Current Assets: 9538300000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1431800000.00
IVZ cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 40100000.00
IVZ income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 9700000.00
IVZ cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 40100000.00
IVZ income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 9700000.00
IVZ income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 455200000.00
IVZ income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.03
IVZ income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -12500000.00
IVZ cash_flow (quarterly, 2025-06-30) — Dividend Received Cfo: -4400000.00
IVZ cash_flow (quarterly, 2025-06-30) — Dividends Received Cfi: 31800000.00
IVZ income_statement (quarterly, 2025-06-30) — EBIT: 295100000.00
IVZ income_statement (quarterly, 2025-06-30) — EBITDA: 335200000.00
IVZ income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 25000000.00
IVZ cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: -25000000.00
IVZ cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 70800000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 716400000.00
IVZ cash_flow (quarterly, 2025-06-30) — End Cash Position: 1491900000.00
IVZ cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -724800000.00
IVZ cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 530400000.00
IVZ cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 33600000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -664200000.00
IVZ income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 139200000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Goodwill: 8583300000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 14334600000.00
IVZ income_statement (quarterly, 2025-06-30) — Gross Profit: 504400000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Held To Maturity Securities: 753900000.00
IVZ income_statement (quarterly, 2025-06-30) — Interest Expense: 20700000.00
IVZ income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 20700000.00
IVZ income_statement (quarterly, 2025-06-30) — Interest Income: 10500000.00
IVZ income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 10500000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Invested Capital: 12746500000.00
IVZ cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -275400000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Investment Properties: 414100000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 1266800000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 2520000000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Investments In Other Ventures Under Equity Method: 1223800000.00
IVZ cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 2839600000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Loans Receivable: 6943600000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 1883900000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1883900000.00
IVZ cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 1155100000.00
IVZ cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -559100000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 1223800000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Minority Interest: 1085800000.00
IVZ income_statement (quarterly, 2025-06-30) — Minority Interests: 6000000.00
IVZ cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -25500000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Net Debt: 392000000.00
IVZ income_statement (quarterly, 2025-06-30) — Net Income: 203400000.00
IVZ income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -12500000.00
IVZ income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 197400000.00
IVZ income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 203400000.00
IVZ income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 203400000.00
IVZ cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 197400000.00
IVZ income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 197400000.00
IVZ income_statement (quarterly, 2025-06-30) — Net Interest Income: -10200000.00
IVZ cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -289700000.00
IVZ cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 596000000.00
IVZ cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 596000000.00
IVZ income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -10200000.00
IVZ cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 6500000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Net PPE: 453600000.00
IVZ cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -17500000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -461500000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 1313400000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 1313400000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Non Current Note Receivables: 6943600000.00
IVZ income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 335200000.00
IVZ income_statement (quarterly, 2025-06-30) — Normalized Income: 203400000.00
IVZ cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 547900000.00
IVZ cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 8600000.00
IVZ income_statement (quarterly, 2025-06-30) — Operating Income: 214200000.00
IVZ income_statement (quarterly, 2025-06-30) — Operating Revenue: 1467300000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 446000000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -664200000.00
IVZ income_statement (quarterly, 2025-06-30) — Other Gand A: 139200000.00
IVZ income_statement (quarterly, 2025-06-30) — Other Income Expense: 70400000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 5751300000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Other Investments: 29400000.00
IVZ cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -76400000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1236300000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 8192500000.00
IVZ income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 45400000.00
IVZ income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 118200000.00
IVZ income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 159300000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Payables: 1431800000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1431800000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 3010500000.00
IVZ cash_flow (quarterly, 2025-06-30) — Preferred Stock Dividend Paid: -56600000.00
IVZ income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 56600000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 3010500000.00
IVZ income_statement (quarterly, 2025-06-30) — Pretax Income: 274400000.00
IVZ cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -1108900000.00
IVZ cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -17500000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Receivables: 8046400000.00
IVZ income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 980700000.00
IVZ income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 40100000.00
IVZ cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -2243600000.00
IVZ cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -1175500000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 6961300000.00
IVZ cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 819200000.00
IVZ income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 23100000.00
IVZ income_statement (quarterly, 2025-06-30) — Selling General And Administration: 162300000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Share Issued: 566200000.00
IVZ cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 23700000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 13873100000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -3472000000.00
IVZ income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
IVZ income_statement (quarterly, 2025-06-30) — Tax Provision: 77000000.00
IVZ income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.28
IVZ balance_sheet (quarterly, 2025-06-30) — Total Assets: 28496900000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 15757000000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Total Debt: 1883900000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 14958900000.00
IVZ income_statement (quarterly, 2025-06-30) — Total Expenses: 1301300000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 13538000000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 18958600000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 12106200000.00
IVZ income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 214200000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 120200000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 2797800000.00
IVZ balance_sheet (quarterly, 2025-06-30) — Working Capital: 8106500000.00
IVZ income_statement (quarterly, 2025-09-30) — +Operating Expense: 289600000.00
IVZ income_statement (quarterly, 2025-09-30) — +Total Revenue: 1640400000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1496200000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1152700000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 7253900000.00
IVZ income_statement (quarterly, 2025-09-30) — Amortization: 9000000.00
IVZ income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 9000000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 474800000.00
IVZ income_statement (quarterly, 2025-09-30) — Basic Average Shares: 452400000.00
IVZ income_statement (quarterly, 2025-09-30) — Basic EPS: 0.67
IVZ cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1491900000.00
IVZ cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -19800000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Capital Stock: 3123700000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1523800000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1523800000.00
IVZ cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -139400000.00
IVZ cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -310100000.00
IVZ cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -254800000.00
IVZ cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 606200000.00
IVZ cash_flow (quarterly, 2025-09-30) — Change In Payable: 284100000.00
IVZ cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 284100000.00
IVZ cash_flow (quarterly, 2025-09-30) — Change In Receivables: -97100000.00
IVZ cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 187000000.00
IVZ cash_flow (quarterly, 2025-09-30) — Changes In Cash: 41300000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Common Stock: 113200000.00
IVZ cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -95000000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 10995100000.00
IVZ cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -29200000.00
IVZ income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1079900000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Current Assets: 10022000000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1496200000.00
IVZ cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 38300000.00
IVZ income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 9000000.00
IVZ cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 38300000.00
IVZ income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 9000000.00
IVZ income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 454600000.00
IVZ income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.66
IVZ income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 301300000.00
IVZ cash_flow (quarterly, 2025-09-30) — Dividend Received Cfo: 39200000.00
IVZ cash_flow (quarterly, 2025-09-30) — Dividends Received Cfi: -14700000.00
IVZ income_statement (quarterly, 2025-09-30) — EBIT: 372400000.00
IVZ income_statement (quarterly, 2025-09-30) — EBITDA: 410700000.00
IVZ income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 34800000.00
IVZ cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -34800000.00
IVZ cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -9400000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 893000000.00
IVZ cash_flow (quarterly, 2025-09-30) — End Cash Position: 1523800000.00
IVZ cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -310100000.00
IVZ cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 586400000.00
IVZ cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -16900000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -735700000.00
IVZ income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 151300000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Goodwill: 8459800000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 14191000000.00
IVZ income_statement (quarterly, 2025-09-30) — Gross Profit: 560500000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Held To Maturity Securities: 770700000.00
IVZ income_statement (quarterly, 2025-09-30) — Interest Expense: 25700000.00
IVZ income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 25700000.00
IVZ income_statement (quarterly, 2025-09-30) — Interest Income: 10500000.00
IVZ income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 10500000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Invested Capital: 12619700000.00
IVZ cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -254800000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Investment Properties: 0.00
IVZ balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 1245500000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 2482000000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Investments In Other Ventures Under Equity Method: 1207000000.00
IVZ cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 1304900000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Loans Receivable: 7345500000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1624600000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1624600000.00
IVZ cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 2989400000.00
IVZ cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -3176700000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 1207000000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Minority Interest: 786700000.00
IVZ income_statement (quarterly, 2025-09-30) — Minority Interests: -10700000.00
IVZ cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -29200000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Net Debt: 100800000.00
IVZ income_statement (quarterly, 2025-09-30) — Net Income: 345700000.00
IVZ income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 301300000.00
IVZ income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 356400000.00
IVZ income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 345700000.00
IVZ income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 345700000.00
IVZ cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 356400000.00
IVZ income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 356400000.00
IVZ income_statement (quarterly, 2025-09-30) — Net Interest Income: -15200000.00
IVZ cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -220300000.00
IVZ cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -187300000.00
IVZ cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -187300000.00
IVZ income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -15200000.00
IVZ cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 45800000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Net PPE: 387700000.00
IVZ cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -19800000.00
IVZ cash_flow (quarterly, 2025-09-30) — Net Preferred Stock Issuance: 0.00
IVZ balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -185400000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 1318800000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 1318800000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Non Current Note Receivables: 7345500000.00
IVZ income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 410700000.00
IVZ income_statement (quarterly, 2025-09-30) — Normalized Income: 345700000.00
IVZ cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 606200000.00
IVZ cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -51700000.00
IVZ income_statement (quarterly, 2025-09-30) — Operating Income: 270900000.00
IVZ income_statement (quarterly, 2025-09-30) — Operating Revenue: 1591900000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 445092900.00
IVZ balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -735700000.00
IVZ income_statement (quarterly, 2025-09-30) — Other Gand A: 151300000.00
IVZ income_statement (quarterly, 2025-09-30) — Other Income Expense: 91000000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 5731200000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Other Investments: 29500000.00
IVZ cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 16100000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1356200000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 8314000000.00
IVZ income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 56200000.00
IVZ income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 109200000.00
IVZ income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
IVZ balance_sheet (quarterly, 2025-09-30) — Payables: 1496200000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1496200000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 3010500000.00
IVZ cash_flow (quarterly, 2025-09-30) — Preferred Stock Dividend Paid: -44400000.00
IVZ income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 44400000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 3010500000.00
IVZ cash_flow (quarterly, 2025-09-30) — Preferred Stock Payments: 0.00
IVZ income_statement (quarterly, 2025-09-30) — Pretax Income: 346700000.00
IVZ cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -1153600000.00
IVZ cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -19800000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Receivables: 8498200000.00
IVZ income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1050600000.00
IVZ income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 38300000.00
IVZ cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -1492200000.00
IVZ cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -29200000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 7167600000.00
IVZ cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 933300000.00
IVZ income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 20100000.00
IVZ income_statement (quarterly, 2025-09-30) — Selling General And Administration: 171400000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Share Issued: 566163773.00
IVZ cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 20900000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 14005600000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -3195900000.00
IVZ income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
IVZ income_statement (quarterly, 2025-09-30) — Tax Provision: -9700000.00
IVZ income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
IVZ balance_sheet (quarterly, 2025-09-30) — Total Assets: 28438900000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 15630200000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Total Debt: 1624600000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 14792300000.00
IVZ income_statement (quarterly, 2025-09-30) — Total Expenses: 1369500000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 13646600000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 18416900000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 12150400000.00
IVZ income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 270900000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 121070873.00
IVZ balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 2803900000.00
IVZ balance_sheet (quarterly, 2025-09-30) — Working Capital: 8525800000.00
IVZ income_statement (annual, 2025-12-31) — +Operating Expense: 2942900000.00
IVZ income_statement (quarterly, 2025-12-31) — +Operating Expense: 2084800000.00
IVZ income_statement (annual, 2025-12-31) — +Total Revenue: 6377100000.00
IVZ income_statement (quarterly, 2025-12-31) — +Total Revenue: 1692000000.00
IVZ balance_sheet (annual, 2025-12-31) — Accounts Payable: 20400000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 20400000.00
IVZ balance_sheet (annual, 2025-12-31) — Accounts Receivable: 1150800000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 1150800000.00
IVZ balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -910000000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -910000000.00
IVZ balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 7269100000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 7269100000.00
IVZ income_statement (annual, 2025-12-31) — Amortization: 1832400000.00
IVZ income_statement (quarterly, 2025-12-31) — Amortization: 1803600000.00
IVZ income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 1832400000.00
IVZ income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 1803600000.00
IVZ cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 1794900000.00
IVZ balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 604300000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 604300000.00
IVZ income_statement (annual, 2025-12-31) — Basic Average Shares: 452600000.00
IVZ income_statement (quarterly, 2025-12-31) — Basic Average Shares: 451200000.00
IVZ income_statement (annual, 2025-12-31) — Basic EPS: -1.60
IVZ income_statement (quarterly, 2025-12-31) — Basic EPS: -2.63
IVZ cash_flow (annual, 2025-12-31) — Beginning Cash Position: 1496000000.00
IVZ cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1523800000.00
IVZ cash_flow (annual, 2025-12-31) — Capital Expenditure: -84300000.00
IVZ cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -23600000.00
IVZ balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 406700000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 406700000.00
IVZ balance_sheet (annual, 2025-12-31) — Capital Stock: 2623700000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2623700000.00
IVZ balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1979800000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1979800000.00
IVZ balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1979800000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1979800000.00
IVZ cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -581900000.00
IVZ cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -139000000.00
IVZ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -149500000.00
IVZ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 356100000.00
IVZ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -974400000.00
IVZ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -352200000.00
IVZ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1525300000.00
IVZ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 455800000.00
IVZ cash_flow (annual, 2025-12-31) — Change In Payable: -210800000.00
IVZ cash_flow (quarterly, 2025-12-31) — Change In Payable: -362200000.00
IVZ cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -210800000.00
IVZ cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -362200000.00
IVZ cash_flow (annual, 2025-12-31) — Change In Receivables: -5600000.00
IVZ cash_flow (quarterly, 2025-12-31) — Change In Receivables: 117600000.00
IVZ cash_flow (annual, 2025-12-31) — Change In Working Capital: -216400000.00
IVZ cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -244600000.00
IVZ cash_flow (annual, 2025-12-31) — Changes In Cash: 401400000.00
IVZ cash_flow (quarterly, 2025-12-31) — Changes In Cash: 459700000.00
IVZ balance_sheet (annual, 2025-12-31) — Common Stock: 113200000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Common Stock: 113200000.00
IVZ cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -377300000.00
IVZ cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -94600000.00
IVZ balance_sheet (annual, 2025-12-31) — Common Stock Equity: 9720500000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 9720500000.00
IVZ cash_flow (annual, 2025-12-31) — Common Stock Payments: -123600000.00
IVZ cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -25800000.00
IVZ balance_sheet (annual, 2025-12-31) — Construction In Progress: 30000000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 30000000.00
IVZ income_statement (annual, 2025-12-31) — Cost Of Revenue: 4129900000.00
IVZ income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1065300000.00
IVZ balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 665500000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 665500000.00
IVZ balance_sheet (annual, 2025-12-31) — Current Assets: 10765800000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Current Assets: 10765800000.00
IVZ balance_sheet (annual, 2025-12-31) — Current Liabilities: 897000000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 897000000.00
IVZ cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 155900000.00
IVZ cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 36000000.00
IVZ income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 1832400000.00
IVZ income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 1803600000.00